NCT04139642

Brief Summary

This 18-month prospective, observational study involving real world data will determine if the use of a standing scale that delivers a quantitative measure of standing balance along with weight (balance + weight) in place of a scale that only delivers weight (weight only) influences clinical decision making by health care practitioners in the ambulatory outpatient setting. Providers will be randomized to receive the balance+weight scale or weight-only scale for 9 months, then to crossover and receive the other for 9 months. The primary outcome measures are (1) providers' self-reported perceptions of whether the balance measurement influences their clinical decision making and (2) the rate of performing falls risk assessments or referring to a specialist for evaluation and treatment based on aggregate billing data. The secondary outcome measure is qualitative interviews with practitioners regarding their perceptions on the utility and barriers to using the device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 25, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

March 2, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2022

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

October 25, 2023

Completed
Last Updated

October 25, 2023

Status Verified

September 1, 2023

Enrollment Period

2.2 years

First QC Date

October 21, 2019

Results QC Date

August 24, 2023

Last Update Submit

September 29, 2023

Conditions

Keywords

descriptive observational studybalance measurement

Outcome Measures

Primary Outcomes (3)

  • Percentage of Balance-Related Diagnoses

    Percent of unique visits with a balance-related diagnosis

    Historical control period plus 18-month intervention period

  • Number of Unique Visits With and Without Balance-Related Referrals

    Difference in the rate of performing falls risk assessments or referring to a specialist for evaluation and treatment based on aggregate billing data when the provider has the device versus when the provider does not have the device.

    at conclusion of second intervention period (18 months)

  • Providers' Perceptions Reported as Number of Responses

    Providers' self-reported perceptions of whether the balance measurement influences their clinical decision making.

    through study completion, an average of 18 months

Study Arms (2)

Group AB

A block randomization scheme by clinic type will be used to assign which clinics receive the Balance+Weight device in the first 9 months and which clinics receive the Balance+Weight device in the second 9 months. The block randomization scheme is proposed instead of simple randomization because of the expected variation between clinics in the types of patients they see. At the 9-month point, OSU personnel will go to every site to reprogram each device from Balance+Weight mode to Weight Only mode or vice versa, and to move the immediate feedback kiosks to the new Balance+Weight sites.

Device: SimpleSway

Group BA

A block randomization scheme by clinic type will be used to assign which clinics receive the Balance+Weight device in the first 9 months and which clinics receive the Balance+Weight device in the second 9 months. The block randomization scheme is proposed instead of simple randomization because of the expected variation between clinics in the types of patients they see. At the 9-month point, OSU personnel will go to every site to reprogram each device from Balance+Weight mode to Weight Only mode or vice versa, and to move the immediate feedback kiosks to the new Balance+Weight sites.

Device: SimpleSway

Interventions

During the 9-month period each practitioner who receives the balance + weight device is asked to provide anonymous feedback via a kiosk regarding if the balance data influenced clinical decision making after every patient. The kiosk has four marked buttons indicating a 4-point Likert Scale, so the practitioner just presses one of the four buttons to indicate their agreement with the statement, "The balance measurement influenced my clinical decision making with this patient." After 9 months, the devices are switched so that every practitioner who had a weight only device receives balance + weight device and vice versa. After the second 9-month period concludes all devices will be retrieved by study personnel, and participants will be asked to complete surveys regarding their experience and attend group feedback sessions regarding their experiences.

Group ABGroup BA

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will include physicians, advanced practice registered nurses, and physician assistants who diagnose and treat patients in ambulatory outpatient settings. Participants must commit to using the test device as the primary weight scale in the clinic for the duration of the study to be selected. Participants will be identified through word-of-mouth and email announcements distributed by the organizations listed above. Any additional organizations that express interest will also be encouraged to distribute announcements to their employees.

You may qualify if:

  • Columbus Metropolitan Area by the following counties: Franklin, Madison, Union, Delaware, Locking, Fairfield, Pickaway.
  • Physician, advanced practice registered nurse, or physician assistant, who diagnoses and treats patients in ambulatory outpatient settings
  • self-report that falls are a concern for a significant fraction of the participant's patients, where the participants defines significant as they see fit.
  • Participants must commit to using the test device as the primary weight scale in the clinic for the duration of the study to be selected.

You may not qualify if:

  • No gender, ethnic, or racial groups will be excluded from this study, though it is expected that the majority of the sample will be Caucasian American, given that the professions of physicians, nurse practitioners, and physician assistants are predominantly Caucasian American.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43021, United States

Location

Related Publications (1)

  • Casey CM, Parker EM, Winkler G, Liu X, Lambert GH, Eckstrom E. Lessons Learned From Implementing CDC's STEADI Falls Prevention Algorithm in Primary Care. Gerontologist. 2017 Aug;57(4):787-796. doi: 10.1093/geront/gnw074. Epub 2016 Apr 29.

Limitations and Caveats

Intervention was likely affected by the COVID-19 pandemic affecting both volume and characteristics of the patients visiting the clinics of the providers who participated in the study. Several provider participants noted in post-intervention focus groups that they were unable to implement the intervention device into their clinical workflow due to pandemic-related workforce shortages and turnover.

Results Point of Contact

Title
Dr. Ajit Chaudhari
Organization
The Ohio State University

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Target Duration
18 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Physical Therapy, Orthopaedics, Mechanical Engineering, and Biomedical Engineering

Study Record Dates

First Submitted

October 21, 2019

First Posted

October 25, 2019

Study Start

March 2, 2020

Primary Completion

April 30, 2022

Study Completion

August 31, 2022

Last Updated

October 25, 2023

Results First Posted

October 25, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.

Locations